4th Quarter - Report

ORGANOGENESIS INC. for ORGANOGENESIS INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$10,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 18, 2022 $10,000 Replaced
4th Quarter - Amendment Jan 18, 2022 $50,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Department of Defense research and development funding regarding regenerative medicine products

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare reimbursement policy for chronic wound healing products Hospital Outpatient Prospective Payment System proposed regulation regarding reimbursement for chronic wound healing product

LobbyistCovered position, as disclosed
ARTHUR-PAUL PETROSINELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.